跳至主要内容
临床试验/NL-OMON56593
NL-OMON56593招募中不适用

A comparison of nigrostriatal dopaminergic functioning in healthy adults of West-African and European descent - The relationship between ancestry and dopamine in the brain

Amsterdam UMC0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age 18-70 years old.
  • 2. West-African or Dutch descent, as determined through self-report (parents
  • and grandparents should be born in the corresponding region). After the study
  • has been conducted, ancestry will be confirmed with genetic analysis.
  • 3. Speaks Dutch or English.

排除标准

  • 1. Present or past (suspected) presence of severe psychiatric illness, such as
  • schizophrenia or other psychotic disorder, bipolar disorder, depressive
  • disorder with psychotic features.
  • 2. Present or past (suspected) presence of neurological disorder (e.g.,
  • Parkinson*s disease, epilepsy), evidence of brain damage, and/or other medical
  • illness (e.g., diabetes mellitus) that may affect brain function.
  • 3. Current or recent (past three months) use of illicit drugs, as determined by
  • self-report and with a urinary drug test on the day of neuroimaging (the
  • results of this drug test will be checked after the participant has completed
  • the study). Participants will be tested on use of cannabis, amphetamines, XTC,
  • cocaine and opiates.
  • 4. Lifetime use of illicit drugs (in particular opiates, amphetamines, XTC, and
  • cocaine; exclusion for other illicit drug use will be decided on a case-by-case
  • basis), if frequently taken (>10x lifetime use of drugs).
  • 5. Lifetime cannabis use, if frequently taken (weekly use for at least a year).
  • 6. Current or recent (past three months) use of dopamine-altering
  • medications/drugs that might influence neuroimaging of DAT availability,
  • namely: amphetamines, cannabis, cocaine, CNS stimulants phentermine or
  • ephedrines, modafinil, certain antidepressants (mazindol, bupropion,
  • radafaxine), adrenergic agonists, anticholinergic drugs, opioids, anesthetics
  • ketamine, PCP, or isoflurane.
  • 7. Smoking or consuming caffeinated drinks during the period of six hours prior
  • to the DAT SPECT scan.
  • 8. Participation in a scientific examination that used radiation, in the last
  • 9. (Non-removable) metal objects in or around the body.
  • 10. In women: pregnancy (self-report or positive pregnancy test) and/or

研究者

发起方
Amsterdam UMC

相似试验